Phân tích
Phân tích chuyên sâu về thị trường dược, chuỗi cung ứng, công nghệ và quy định
#US market entry ×
Phân tích
1 thg 9, 2026•1 phút đọc
HK Innoen's K‑Cap (Tegoprazan) Targets US Launch, Boosts Growth Prospects
Domestic drug K‑Cap (tegoprazan) is nearing US market entry, with analysts seeing royalty revenue and a shift to global growth for HK Innoen.
Phân tích
30 thg 8, 2026•1 phút đọc
WiseBuzz Forms US DTC Advertising Team to Support Korean Pharma Expansion
WiseBuzz announced the creation of a dedicated US Direct‑to‑Consumer advertising team to help Korean pharma and biotech firms launch DTC campaigns in the United States.